Mirtazapine Shortage: What Providers and Prescribers Need to Know in 2026

Mirtazapine is a commonly prescribed atypical antidepressant used for major depressive disorder, off-label insomnia, anxiety, and appetite stimulation. While no national FDA shortage has been declared as of 2026, clinicians are increasingly hearing from patients who cannot fill their mirtazapine prescriptions at their local pharmacy. This guide provides clinical context, prescribing considerations, and practical tools to help your patients navigate these localized supply disruptions.

Current Availability Status

As of 2026, mirtazapine is not listed on the FDA's official drug shortage database. It is a multi-source generic drug approved for use in multiple strengths (7.5 mg, 15 mg, 30 mg, and 45 mg tablets; 15 mg, 30 mg, and 45 mg ODT) with multiple manufacturers including Aurobindo, Zydus, Teva, Mylan, and others. National supply is generally stable.

Despite this, localized shortfalls occur for several reasons:

Pharmacy-level just-in-time inventory practices

Mid-level distributor inventory gaps

Increasing off-label demand for insomnia, anxiety, and palliative appetite stimulation

Less commonly stocked presentations (7.5 mg tablet, ODT formulations)

Clinical Risks of Mirtazapine Discontinuation

Clinicians should be alert to the risks of abrupt mirtazapine discontinuation. Patients who cannot obtain their medication may stop suddenly, leading to:

Antidepressant discontinuation syndrome: Dizziness, nausea, rebound insomnia, anxiety, and irritability

Worsening depression: Relapse risk is elevated when treatment is interrupted, particularly in patients with recurrent MDD

Rebound insomnia: Patients using mirtazapine primarily for sleep may experience severe insomnia upon abrupt cessation

Weight loss: Especially concerning in palliative care patients or those with eating disorders who depend on mirtazapine's appetite stimulant properties

Prescribing Strategies to Minimize Disruption

Consider these proactive steps for patients on mirtazapine:

Prescribe 90-day supplies when clinically appropriate. Longer supplies reduce pharmacy visit frequency and exposure to short-term stock issues.

Consider mail-order pharmacy. Mail-order pharmacies typically carry broader inventory than retail locations.

Document clinically equivalent doses. If 30 mg tablets are unavailable, note in the chart that two 15 mg tablets are an acceptable substitute.

Cross-taper plan ready. For high-risk patients (severe MDD, palliative), have a documented backup plan for switching if mirtazapine becomes truly unavailable for more than a few days.

Potential Alternatives by Indication

For MDD: SSRIs (sertraline, escitalopram) and SNRIs (venlafaxine, duloxetine) are the primary evidence-based alternatives, though these should not be substituted without considering the patient's SSRI/SNRI history. Bupropion is an option for patients without seizure risk or eating disorder history.

For insomnia (off-label use): Trazodone (25-100 mg QHS), low-dose quetiapine (off-label), doxepin (Silenor), or non-pharmacologic cognitive behavioral therapy for insomnia (CBT-I) are common alternatives.

For appetite stimulation (palliative/oncology): Megestrol, dronabinol, or olanzapine (which shares appetite-stimulating properties) may be considered in appropriate clinical contexts.

Drug Interaction Considerations When Switching

Any switch from mirtazapine requires careful review of the patient's medication list. Key considerations include:

A 14-day washout is required before and after MAOI use

Combining mirtazapine (even during taper) with other serotonergic agents risks serotonin syndrome

CYP1A2/2D6/3A4 inducers and inhibitors affect mirtazapine plasma levels — relevant when initiating alternative drugs that share these pathways

A Tool for Your Patients: medfinder

Rather than sending patients to call every pharmacy themselves, consider recommending medfinder — a service that contacts pharmacies in a patient's area to check medication availability and texts them results. This is particularly useful for elderly or anxious patients who may struggle with lengthy phone calls.

Read our provider-focused companion guide: How to help your patients find mirtazapine in stock.